Heparin Derivatives as Angiogenesis Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|7|553-566

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.7, 2003-03, pp. : 553-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

New setback for angiogenesis inhibitors

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Breakthrough for angiogenesis inhibitors

By  

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Src Inhibitors and Angiogenesis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2118-2128

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Evaluation of 1-Benzhydryl-sulfonyl-piperazine Derivatives as Inhibitors of Tumor Growth and Tumor Angiogenesis of Mouse Ehrlich Ascites Tumor In Vivo

By  

Medicinal Chemistry, Vol. 4, Iss. 5, 2008-09 ,pp. : 466-472

Bentham Science Publishers

Access to resources Recommend Favorite